Determining the Most Efficient Screening Cut Off Levels for Phenylketonuria (PKU)
NCT06629987 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 360
Last updated 2024-10-09
Summary
studying the screening of PKU in france with the new tandemMS
Conditions
- PKU
Sponsors & Collaborators
-
University Hospital, Lille
collaborator OTHER -
Hospices Civils de Lyon
collaborator OTHER -
University Hospital, Strasbourg, France
collaborator OTHER -
CHU de Reims
collaborator OTHER -
Centre Hospitalier Universitaire, Amiens
collaborator OTHER -
Centre Hospitalier Universitaire Dijon
collaborator OTHER -
Nantes University Hospital
collaborator OTHER -
University Hospital, Tours
collaborator OTHER -
Clinical Research Center of Reunion island
collaborator UNKNOWN -
University Hospital, Caen
collaborator OTHER -
Rennes University Hospital
collaborator OTHER -
University Hospital, Bordeaux
collaborator OTHER -
University Hospital, Toulouse
collaborator OTHER -
University Hospital, Montpellier
collaborator OTHER -
Central Hospital, Nancy, France
lead OTHER
Eligibility
- Min Age
- 3 Days
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-01-01
- Primary Completion
- 2021-01-01
- Completion
- 2022-12-31
Countries
- France
Study Locations
More Related Trials
-
GMP Drink for PKU Study
NCT02915510 ·Status: COMPLETED ·Phase: NA
-
Evaluating the Efficacy of PKU Synergy in Patients Expressing Phenylketonuria or Hyperphenylalaninemia
NCT03167697 ·Status: COMPLETED ·Phase: NA
-
The Early History of Universal Screening for Metabolic Disorders
NCT00309400 ·Status: COMPLETED
-
Blood Spot and Urine Metabolomic Screening Applied to Rare Diseases
NCT06360913 ·Status: RECRUITING ·Phase: NA
-
Simple Breath Test to Examine Phenylalanine Metabolism
NCT02009904 ·Status: COMPLETED
-
Impact of Phenylalanine Elevations on Brain and Cognition in Adult PKU Carriers
NCT07220265 ·Status: RECRUITING ·Phase: NA
-
A Prospective Clinical Study of Phenylketonuria (PKU)
NCT04452513 ·Status: COMPLETED
-
Effects of Synergy on Nutrient Intake and Acceptability in Phenylketonuria (PKU)
NCT03777826 ·Status: COMPLETED ·Phase: NA
-
Evaluation of PKU Explore
NCT03168399 ·Status: COMPLETED ·Phase: NA
-
A Self-test Home-use Blood Phenylalanine Monitoring System Under the Brand Name Egoo Phe System Has Been Developed for Measurement of Phenylalanine (Phe) in Individuals Diagnosed With Phenylketonuria (PKU): The Study Purpose is to Evaluate Accuracy and Usability
NCT06940193 ·Status: ENROLLING_BY_INVITATION
-
SNAP: Study Nutrients in Adult PKU
NCT03858101 ·Status: COMPLETED
-
Observational Study of Endothelial Dysfunction in Phenylketonuria
NCT02176603 ·Status: COMPLETED
-
Evaluation of BH4 Responsiveness in Our PKU Patients
NCT07255599 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Safety and Efficacy Study of NGGT002 in cPKU Adult Subjects
NCT06687733 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
A Phase 3, Multicenter, Open-Label Extension Study of Phenoptin in Subjects With PKU Who Have Elevated Phenylalanine Levels
NCT00225615 ·Status: COMPLETED ·Phase: PHASE3
-
A Non-Interventional Interview Study of Phenylketonuria (PKU) Adults
NCT03505125 ·Status: COMPLETED
-
Phenylketonuria and Hyperphenylalaninemia Nutrition Study
NCT01879995 ·Status: COMPLETED
-
Evaluation of PKU Sphere Liquid
NCT05096988 ·Status: COMPLETED ·Phase: NA
-
Phosphoproteomic Profile of Children With Down Syndrome
NCT06279208 ·Status: COMPLETED
-
Neurocognitive Outcomes in Mild Hyperphenylalaninemia (MHP)MHP Study
NCT01924026 ·Status: COMPLETED
-
Macrophagic Activation and Immunophenotypic Profile of Patients With Gaucher's Disease
NCT01206673 ·Status: COMPLETED ·Phase: NA
-
A Study of JNT-517 in Participants With Phenylketonuria (PKU)
NCT06971731 ·Status: RECRUITING ·Phase: PHASE3
-
Study of Metabolic Modifications in Children With Noonan Syndrome
NCT02383316 ·Status: COMPLETED ·Phase: NA
-
PheCheck Feasibility Study
NCT05998109 ·Status: COMPLETED
-
Pompe Gene Therapy- Screening for Eligibility
NCT03285126 ·Status: COMPLETED